Goodwin Procter LLP advised Lyra Therapeutics, Inc. on the deal.Lyra Therapeutics, Inc. (Nasdaq: LYRA) announced its strategic partnership and exclusive license agreement with LianBio for the development…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
